115 related articles for article (PubMed ID: 35846251)
1. Metabolic Effects of Recombinant Human Growth Hormone Replacement Therapy on Juvenile Patients after Craniopharyngioma Resection.
Li S; Wang X; Zhao Y; Nie M; Ji W; Mao J; Wu X
Int J Endocrinol; 2022; 2022():7154907. PubMed ID: 35846251
[No Abstract] [Full Text] [Related]
2. [Effect of recombinant human growth hormone therapy on metabolic parameters in patients with craniopharyngioma].
Mao JF; Wang X; Xiong SY; Zheng JJ; Yu BQ; Nie M; Wu XY; Qi ST
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(42):3286-3290. PubMed ID: 29141371
[No Abstract] [Full Text] [Related]
3. Blood Lipid Disorders in Post-Operative Craniopharyngioma Children and Adolescents and the Improvement with Recombinant Human Growth Hormone Replacement.
Du HZ; Chen K; Zhang LY; Zhang YL; Wu DN; Guo XY; Duan L; Wang LJ; Yang HB; Chen S; Pan H; Zhu HJ
Diabetes Metab Syndr Obes; 2023; 16():3075-3084. PubMed ID: 37810571
[TBL] [Abstract][Full Text] [Related]
4. Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery.
Pei LL; Guo Y; Chen H; Zhong LY
J Pediatr Endocrinol Metab; 2023 May; 36(5):484-491. PubMed ID: 36935568
[TBL] [Abstract][Full Text] [Related]
5. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
6. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy.
Riedl M; Ludvik B; Pacini G; Clodi M; Kotzmann H; Wagner O; Kautzky-Willer A; Prager R; Luger A
Eur J Clin Invest; 2000 Sep; 30(9):771-8. PubMed ID: 10998076
[TBL] [Abstract][Full Text] [Related]
7. Safety of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: A Systematic Review and Cohort Study.
van Schaik J; Kormelink E; Kabak E; van Dalen EC; Schouten-van Meeteren AYN; de Vos-Kerkhof E; Bakker B; Fiocco M; Hoving EW; Tissing WJE; van Santen HM
Neuroendocrinology; 2023; 113(10):987-1007. PubMed ID: 37231961
[TBL] [Abstract][Full Text] [Related]
8. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
9. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
[TBL] [Abstract][Full Text] [Related]
11. Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.
Alotaibi NM; Noormohamed N; Cote DJ; Alharthi S; Doucette J; Zaidi HA; Mekary RA; Smith TR
World Neurosurg; 2018 Jan; 109():487-496.e1. PubMed ID: 28987837
[TBL] [Abstract][Full Text] [Related]
12. [Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet].
Yang Q; Zhao H; Zhou AZ; Lou ZH
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):852-858. PubMed ID: 27978932
[No Abstract] [Full Text] [Related]
13. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.
Liang S; Xue J; Li G
Lipids Health Dis; 2018 Apr; 17(1):66. PubMed ID: 29615058
[TBL] [Abstract][Full Text] [Related]
15. Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.
Biscotto IP; Costa Hong VA; Batista RL; Mendonca BB; Arnhold IJP; Bortolotto LA; Carvalho LRS
Pituitary; 2021 Apr; 24(2):216-228. PubMed ID: 33098037
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and quality of life effects of growth hormone replacement in patients with TBI and AGHD: A pilot study.
Herodes M; Le N; Anderson LJ; Migula D; Miranda G; Paulsen L; Garcia JM
Growth Horm IGF Res; 2023 Aug; 71():101544. PubMed ID: 37295336
[TBL] [Abstract][Full Text] [Related]
17. [The gender features of disorders of composition of lipids of blood serum in patients with chronic pathology of kidneys.].
Murkamilov IT; Aytabaiev KA; Fomin VV; Murkamilova ZA; Rayimjanov ZR; Redjapova NA; Yusupov FA; Aydarov ZA
Klin Lab Diagn; 2018; 63(3):152-158. PubMed ID: 30673194
[TBL] [Abstract][Full Text] [Related]
18. Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.
Chen XL; Han YD; Wang H
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5640-5646. PubMed ID: 30229840
[TBL] [Abstract][Full Text] [Related]
19. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
[TBL] [Abstract][Full Text] [Related]
20. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
Li GM; Sun XJ; Shao P
Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]